Kyntra Bio (KYNB) Other Working Capital Changes (2014 - 2026)

Kyntra Bio has reported Other Working Capital Changes for 13 years, with the latest figure at $4.2 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 201.06% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 59.84% YoY) and the FY2025 annual result came in at $495000.0, up 191.67% from the prior year.
• Other Working Capital Changes improved to $4.2 million in Q1 2026 per KYNB's latest filing, from $81000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $52.6 million in Q3 2025 and troughed at -$52.6 million in Q1 2025.
• A 5-year average of $1.6 million and a median of -$170000.0 in 2025 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes tumbled 1536.9% in 2024, then jumped 201.06% in 2026.
• Over 5 years, Other Working Capital Changes stood at $6.1 million in 2022, then soared by 42.92% to $8.8 million in 2023, then jumped by 67.48% to $14.7 million in 2024, then slumped by 99.45% to $81000.0 in 2025, then jumped by 5067.9% to $4.2 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $4.2 million, $81000.0, and -$7.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.